uniQure Announces Financial Results for Third Quarter 2015 and Provides Update on Product Pipeline and Company Developments
November 30, 2015 07:30 ET
|
uniQure
AMSTERDAM, the Netherlands, Nov. 30, 2015 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leader in human gene therapy, today announced financial results for the third quarter and nine months...
uniQure Announces Conference Call and Webcast to Discuss Third Quarter Financial Results and Corporate Update
November 23, 2015 05:35 ET
|
uniQure
AMSTERDAM, the Netherlands, Nov. 23, 2015 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ:QURE), a leader in human gene therapy, today announced that the Company will release its financial results and a...
uniQure to Present at the Jefferies 2015 Global Healthcare Conference - London
November 12, 2015 05:58 ET
|
uniQure
AMSTERDAM, the Netherlands, Nov. 12, 2015 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ:QURE), a leader in human gene therapy, today announced that its management will present at the Jefferies 2015 Global...
uniQure to Host Investor Day in New York City on October 15, 2015
October 07, 2015 08:46 ET
|
uniQure
AMSTERDAM, the Netherlands, Oct. 7, 2015 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ:QURE), a leader in human gene therapy, today announced that it will be hosting an Investor Day and simultaneous...
Positive Topline Results Announced From Phase I/II Trial in Sanfilippo B Syndrome Patients Using uniQure's Novel AAV5-Based Gene Therapy
September 19, 2015 08:12 ET
|
uniQure
--Safety, Durable NaGlu Protein Expression and Positive Signs of Efficacy Demonstrated in All Four Patients--
--First Clinical Validation of AAV5 Vector Effectively Delivering Target Gene into the...
uniQure to Present at NewsMakers in the Biotech Industry Conference - NYC
September 01, 2015 08:59 ET
|
uniQure
AMSTERDAM, Netherlands, Sept. 1, 2015 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq: QURE), a leader in human gene therapy, today announced that its management will present at the NewsMakers in the Biotech...
uniQure Announces Financial Results for Second Quarter 2015
August 27, 2015 05:05 ET
|
uniQure
AMSTERDAM, the Netherlands, Aug. 27, 2015 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leader in human gene therapy, today announced financial results for the second quarter and six months...
uniQure Announces Receipt of $53 Million From Bristol-Myers Squibb for Target Selection Payment and Additional Equity Investment
August 10, 2015 05:00 ET
|
uniQure
AMSTERDAM, the Netherlands, Aug. 10, 2015 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ:QURE), a leader in human gene therapy, today announced the receipt of an additional $53 million from Bristol-Myers...
Dr. Charles W. Richard Joins uniQure as Senior Vice President to Lead Development of CNS-focused Gene Therapy Pipeline
July 16, 2015 05:00 ET
|
uniQure
AMSTERDAM, the Netherlands, July 16, 2015 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ:QURE), a leader in human gene therapy, today announced that Charles W. Richard, M.D., Ph.D., has been hired as Senior...
uniQure Announces Financial Results for First Quarter 2015
June 11, 2015 05:52 ET
|
uniQure
AMSTERDAM, The Netherlands, June 11, 2015 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq:QURE), a leader in human gene therapy, today announced financial results for the first quarter ending March 31, 2015,...